Pharmacy chains activity analysis

Pharmacy chains activity analysis

Russian pharmaceuticals retail chain segment evaluation, both on the level of the state and in particular regions. Pharmacy chains development forecast

Forecasting

Product sales and separate market development forecast, based on unique mathematical models

Business and marketing plan development

Development of detailed business-plans, required to evaluate the reasonability of project start

Search of partners for contract production in Russia

Potential partners search and evaluation, based on their technical opportunities, appropriate experience, and reputation

Monitoring of import substitution

assessment of the main trends of import substitution policies and localization processes in the pharmaceutical market in Russia, the key beneficiaries and companies at risk

News

11/13/2019 Ranking of Russian Pharmaceutical Distributors (Q1 — Q3 2019) November 13, 2019

The Russian pharmaceutical market is developing extremely unevenly in both individual market segments and specific product groups this year. Due to significant cash injections into the public sector, the dynamics in this segment is very different from that in the pharmaceutical retail.

10/29/2019 Database Update: Pharmaceutical Drug Production in Russia (September 2019)

Between January and September 2019, Russia manufactured 295 bln RUB worth of pharmaceutical drugs (manufacturers’ prices, VAT included), which is monetary terms (rubles) 22% higher than that in the same period in 2018. This is also the highest dynamics since 2016. The dynamics in physical terms (units) are +4.7%, or +4.2% if calculated in minimum dosage units (MDU). While these dynamics are far from those in 2016, these can still be considered high after the constant negative dynamics during 2017-2018.

9/26/2019 Database Update: Pharmaceutical Drug Production in Russia (August 2019)

Between January and August 2019, Russia produced 255.8 bln RUB worth of pharmaceutical drugs (manufacturers’ prices, VAT included), which is in monetary terms (rubles) 20.2% higher than that of the same period in 2018. In physical terms, the dynamics are +4.5%, with the production volume of 2.83 bln units. If calculated in minimum dosage units (MDU), the dynamics are +3.5%, with the production volume of 47 bln MDUs.

9/24/2019 Database Update: Import of Veterinary Drugs, Feed Supplements, and APIs to Russia (July 2019)

Between January and July 2019, Russia imported 37.7 bln RUB worth of veterinary products (free circulation prices, VAT included), which is in monetary terms (rubles) 0.1% lower than that of the same period in 2018. The negative dynamics are only due to the import of feed supplements dropping by 12.4%. However, the import of feed supplements is the leader in the volume of import in monetary terms with 19.2 bln RUB. The dynamics in physical terms (units) are only negative, -2.4%.

9/23/2019 Database Update: API Import to Russia (July 2019)

Between January and July 2019, Russia imported 69.5 bln RUB worth of APIs (free circulation prices, VAT included), which is in monetary terms (rubles) 26.5% higher than that of the same period in 2018. As earlier, a significant price increase contributed to the high dynamics. In physical terms (tons), the dynamics are +4.5%, with the import volume of 7 thousand tons.

9/20/2019 Pharmaceutical Drug Import to Russia (July 2019)

In July 2019, Russia imported 61.5 bln RUB worth of ready-made pharmaceuticals (free circulation prices, VAT included), which is in monetary terms (rubles) +31.5% higher than that of July 2018 and the highest volume since August 2010. Higher dynamics were witnessed in June 2016. However, the dynamics in physical terms are only +7.3%, with the import volume of 183.3 bln units.

8/27/2019 Ranking of Russian Pharmaceutical Distributors (Q1 – Q2)

It is unlikely that by the end of this year the pharmaceutical wholesale will have seen any significant achievements or failures. As of yet, the market is only developing in terms of public procurement. The public procurement segment has always been a very specific area, with a limited circle of players and its own rules, which are also very vaguely worded. For example, that massive breakdown in trading due to difficulties in setting the initial maximum price of the contract.

8/20/2019 Database Update: Pharmaceutical Drug Import for Clinical Trials to Russia (June 2019)

Between January and June 2019, Russia imported 319.8 thousand units, 8.2 bln RUB worth of pharmaceuticals for clinical trials (CT) (free circulation prices), which is in physical terms (units) 15.8% lower and in monetary terms (rubles) 1.4% lower than that of the same period in 2018. While the negative dynamics in physical terms have been registered at least thrice since 2013, the negative dynamics in monetary terms have been registered for the first time.

8/16/2019 Ranking of Russian Pharmacy Chains (Q1 – Q2 2019)

By June 2019, the pharmaceutical drug inflation rates have reached a value of 6%, especially against the background of the results of the previous two years. The rising prices, given the decreasing incomes of the population, will obviously be unable to lead to higher demand, and, as a result, the dynamics of the retail and commercial market for the first half of 2019, after a short surge in the first quarter, returned to last year's values, which are closer to stagnation than to growth (+2.4%).

8/15/2019 Database Update: API Import to Russia (June 2019)

Between January and June 2019, Russia imported 56.4 bln RUB worth of APIs (free circulation prices, VAT included), which is in monetary terms (rubles) 21% higher than that of the same period in 2018. In physical terms, Russia imported 5.8 thousand tons of APIs, and the dynamics are +6.1%, if calculated in kilos. 96.6% of the API import accounts for pharmacopoeial APIs.